Digital health company Liva Healthcare has acquired UK-based Momenta, a provider of digital, virtual, and in-person healthy ...

CLAIRE AND EMMETT RECEIVED A $500 AWARD, ENOUGH TO PACK 25 CARE KITS FOR PEOPLE WHO ARE HOMELESS. I WAS SO EXCITED FOR THEM. I MEAN, THIS MADE IT POSSIBLE THAT THEY COULD GO THROUGH THE PROCESS ...

The 19-year-old phenom, who is set to finally take over as a starter in the 2025 season, said he has been bullied by his famous uncles, Peyton and Eli, and they have even given him wedgies.

We took advantage of price dislocations in several leading growth franchises to enhance our health care and consumer discretionary ... to portfolio holding Eli Lilly (LLY) due to delays in scaling ...

The Charlotte Hornets filled the Spectrum Center lobby, assembling 3,000 care kits for U.S. service members Tuesday. It’s an event the organization has held for 11 years. ALSO READ: Hornets ...

With its offering of tirzepatide (branded as Mounjaro and Zepbound), Eli Lilly and Co. (NYSE: LLY) was another key pharma player in this new type of treatment for diabetes and obesity.

In the kitchen of her South St. Paul home, Abigail Turner prepares the insulin she uses to manage her type 1 diabetes last February. Minnesota announced a final settlement Monday with the last of ...

Novo Nordisk agreed to cap insulin prices to settle a lawsuit in which Minnesota's attorney general accused the three largest insulin makers of charging astronomically high prices for the diabetes ...

If Eli Lilly has its way, this may be the future of obesity care. Eli Lilly makes some of the most powerful ... For the past year, Jonsson has run Lilly Diabetes and Obesity, which means he oversees ...

Eli Lilly's small pop was due to the latest developments in the lab reported by Novo Nordisk (NYSE: NVO), which, like the U.S. company, is doing brisk business with a weight loss drug: Wegovy ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the other large-cap value stocks. The market outlook is as uncertain as it gets. On January 18 ...

As evidence has mounted that new diabetes and weight loss drugs can provide a variety of health benefits, the FDA has approved Novo Nordisk’s semaglutide for heart disease and Eli Lilly’s ...